Can asymptomatic patients with a supratherapeutic international normalized ratio be safely treated as outpatients?

Annals of Emergency Medicine

Volumn 59, Issue 4, 2012, Pages 318-320

  Levine, Michael ^a   Ruha, Anne Michelle ^a   Goldstein, Joshua N ^b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; DRUG FATALITY; EMBASE; EPISTAXIS; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; MEDLINE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROPERITONEAL HEMORRHAGE; REVIEW; SOFT TISSUE BLEEDING; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THROMBOEMBOLISM;

AMBULATORY CARE; ANTICOAGULANTS; ASYMPTOMATIC DISEASES; BLOOD COAGULATION DISORDERS; HUMANS; INTERNATIONAL NORMALIZED RATIO; RISK ASSESSMENT; WARFARIN;

EID: 84859031627     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2011.04.023     Document Type: Review

References (20)

1. N.A. Limdi, D.L. Veenstra Warfarin pharmacoginetics Pharmacotherapy 28 2008 1084 1097
2. S.E. Kimmel Warfarin therapy: in need of improvement after all these years Expert Opin Pharmacother 9 2008 677 686 (Pubitemid 351566188)
3. K.A. Cappuzzo Anticoagulation in elderly patients who fall frequently: a therapeutic dilemma Consult Pharm 20 2005 601 605
4. N. Shehab, L.S. Sperling, S.R. Kegler et al. National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin Arch Intern Med 170 2010 1926 1933
5. D.H. Newman, I. Zhitomirsky The prevalence of nontherapeutic and dangerous international normalized ratios among patients receiving warfarin in the emergency department Ann Emerg Med 48 2006 182 189
6. M.A. Crowther, D. Garcia, W. Ageno et al. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10 Thromb Haemost 104 2010 118 121
7. M.A. Crowther, J.D. Douketis, T. Schnurr et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy A randomized, controlled trial Ann Intern Med 137 2002 251 254
8. C.G. Fondevila, S.H. Grosso, M.T. Santarelli et al. Reversal of excessive oral anticoagulation with a low oral dose of vitamin K1 compared with acenocoumarin discontinuation: a prospective, randomized, open study Blood Coagul Fibrinolysis 12 2001 9 16 (Pubitemid 32150246)
9. A. Hung, S. Singh, R.C. Tait A prospective randomized study to determine the optimal dose of intravenous vitamin K in reversal of over-warfarinization Br J Haematol 109 2000 537 539 (Pubitemid 30415179)
10. R. Nee, D. Doppenschmidt, D.J. Donovan et al. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation Am J Cardiol 83 1999 286283
11. G. Raj, R. Kumar, W.P. McKinney Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione Arch Intern Med 159 1999 2721 2724
12. A. Lubetsky, H. Yonath, D. Olchovsky et al. Comparison of oral versus intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study Arch Intern Med 163 2003 2469 2473 (Pubitemid 37385789)
13. V. Pengo, A. Banzato, E. Garelli et al. Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation Blood Coagul Fibrinolysis 4 1993 739 741 (Pubitemid 23343397)
14. R.J. Patel, D.M. Witt, J.J. Saseen et al. Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation Pharmacotherapy 20 2000 1159 1166
15. K.E. Gunther, G. Conway, L. Leibach et al. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR >10 Thromb Res 113 2004 205 209 (Pubitemid 38609405)
16. E.M. Hylek, Y.C. Chang, S.J. Skates et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation Arch Intern Med 160 2000 1612 1617 (Pubitemid 30367900)
17. G. Denas, F. Marzot, P. Offelli et al. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases J Thromb Thrombolysis 27 2009 340 347
18. M.A. Crowther, W. Ageno, D. Garcia et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin Ann Intern Med 150 2009 293 300
19. W. Angeno, M. Crowther, L. Steidel et al. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial Thromb Haemost 88 2002 48 51 (Pubitemid 34759875)
20. D.A. Garcia, S. Regan, M. Crowther et al. The risk of hemorrhage among patients with warfarin-associated coagulopathy J Am Coll Cardiol 47 2006 804 808 (Pubitemid 43243105)